The global ambulatory blood pressure monitoring devices market size was USD 186.7 Mn in 2022 and is likely to reach USD 335.2 Mn by 2031, expanding at a CAGR of 7.3% during 2023 – 2031. Increasing demand for portable and remote blood pressure monitoring systems, due to the rising conditions of hypertension and cardiovascular diseases among the aging population, is projected to fuel the market.
Ambulatory blood pressure monitoring (ABPM) devices are portable devices worn by patients to measure and record blood pressure on a continuous basis for 24 hours. These devices provide a comprehensive and accurate assessment of an individual's blood pressure from a remote location than a single isolated measurement taken in a doctor's office.
ABPM devices help in diagnosing and managing conditions such as hypertension. These devices capture fluctuations in hypertension. Measurements are taken continuously at an interval of 20 to 30 minutes, which allows doctors to identify patterns and abnormalities that go unnoticed during daily checkups. Furthermore, these devices help doctors to make informed treatment decisions, such as adjusting medication dosages or prescribing lifestyle modifications to control blood pressure and reduce the risk of cardiovascular disease.
The COVID-19 pandemic moderately impacted the ambulatory blood pressure monitoring devices market. The pandemic increased the focus on telemedicine and remote patient monitoring. Lockdown restrictions on in-person visits and the need for social distancing have raised the demand for virtual consultations and remote patient monitoring options.
Ambulatory blood pressure monitoring devices with their ability to provide continuous blood pressure data over an extended period became valuable tools in remote patient monitoring during the pandemic to reduce unnecessary visits to hospitals. However, the COVID-19 pandemic posed challenges to the ambulatory blood pressure monitoring devices market. Supply chain disruptions, reduced manufacturing capacity, and logistical constraints have affected the production and distribution of these devices, which slowed down revenue generation to a certain limit.
Ambulatory Blood Pressure Monitoring Devices Market Dynamics
Major Drivers
Rising elderly population and increasing prevalence of hypertension (HTN)across the globe are expected to drive the market during the forecast period. The aging population is often associated with high risk of developing chronic health conditions, including hypertension. Factors such as sedentary lifestyles, unhealthy diets, and work stress contribute to the increasing incidence of hypertension among individuals. Ambulatory blood pressure monitoring devices enable healthcare professionals to identify and monitor individuals with hypertension effectively. This facilitates the implementation of timely interventions, including lifestyle modifications and medication management, to control blood pressure and reduce the risk of associated complications.
-
According to the report published by WHO, globally, about 1.28 billion people between the ages of 30 to 79 years suffer from hypertension. Furthermore, approximately 46% of these patients with this condition are unaware of their condition and do not receive the required diagnosis and necessary treatment.
Growing incidence of obesity is driving the ambulatory blood pressure monitoring devices market. Obesity is closely linked to the development of hypertension, as excess body weight puts additional strain on the cardiovascular system and leads to elevated blood pressure levels. ABPM devices capture fluctuations or abnormalities continuously that are missed out during hospital visits. This comprehensive monitoring enables healthcare professionals to manage hypertension in individuals with obesity.
-
As per WHO, about 1.9 billion adults aged 18 years and above and over 340million children across the world were overweight in 2016. Nearly 39million children under the age of 5 were overweight in 2020. Furthermore, this number is expected to increase in the next few years.
Existing Restraints
High developmental cost of ambulatory blood pressure monitoring devices is expected to hinder the market in the coming years. These devices require significant investments in research and development to ensure accuracy, reliability, and compliance with regulatory standards. Developmental costs of these devices include expenses associated with designing, prototyping, clinical testing, and obtaining regulatory approvals. This poses challenges for healthcare providers and patients, especially in regions with limited healthcare budgets to adopt this technology, which further restrains the market growth.
Emerging Opportunities
Increasing research activities and the rising adoption of advanced technologies are likely to create immense opportunities for the key players competing in the market. Innovations such as wearable devices, wireless connectivity, and data analytics capabilities enhance the functionality and usability of these monitoring devices. Wearable devices in the form of smartwatches or patches provide continuous monitoring without causing discomfort to the wearer. Integration of wireless connectivity allows for seamless data transmission, enabling healthcare professionals to remotely access and analyze blood pressure measurements. Data analytics capabilities facilitate the interpretation of large volumes of data, leading to accurate diagnoses and personalized treatment strategies, improving patient outcomes.
Scope of the Ambulatory Blood Pressure Monitoring Devices Market Report
The report on the market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Ambulatory Blood Pressure Monitoring Devices Market- Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Product Type (Arm Devices and Wrist Devices) and End-user (Hospitals, Ambulatory Surgical Centers, Home Healthcare, and Others)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Welch Allyn®; Vaso Corporation; SunTech Medical, Inc; Schiller AG; Rudolf Riester GmbH; OSI Systems, Inc; OMRON Healthcare, Inc; Halma Plc; GE HealthCare; Daifuku Co., Ltd.; CONTEC MEDICAL SYSTEMS CO., LTD; BPL Limited; BOSCH + SOHN GmbH u. Co. KG; and Baxter
|
Market Segment Insights
Product Type Segment Analysis
Based on product type, the ambulatory blood pressure monitoring devices market is bifurcated into arm devices and wrist devices. The arm devices segment is expected to hold a major market share during the forecast period, due to its established credibility and compatibility with various arm sizes. Arm ambulatory blood pressure monitoring devices have been widely adopted and recognized as a standard method for measuring blood pressure. These devices offer accurate and reliable readings by utilizing a cuff placed around the upper arm, which is known to provide consistent measurements.
The wrist devices segment is anticipated to register robust growth in the coming years, owing to their convenience, portability, improved accuracy, and compatibility with digital health devices and telemedicine. These devices are compact and lightweight, making them easy to carry and wear throughout the monitoring period. The wrist-based design eliminates the need for bulky upper arm cuffs, which provides comfort for patients. This enhanced comfort and ease of use contribute to improved patient compliance and acceptance of wrist devices.
End-user Segment Analysis
In terms of end-user, the market is fragmented into hospitals, ambulatory surgical centers, home healthcare, and others. The hospitals segment is estimated to hold a key market share during the forecast period, due to its central role in the diagnosis, treatment, and management of various medical conditions, including hypertension and cardiovascular diseases. Ambulatory blood pressure monitoring devices are extensively used in hospitals to obtain accurate and comprehensive blood pressure measurements over an extended period. Availability of specialized medical staff, infrastructure, and resources in hospitals enables efficient and effective utilization of these devices.
Hospitals often deal with a high volume of patients, including those with complex medical conditions and comorbidities. Ambulatory blood pressure monitoring provides valuable insights into the blood pressure patterns of patients, enabling healthcare professionals to make informed decisions regarding diagnosis, medication adjustments, and treatment plans.
The ambulatory surgical centers segment is projected to expand at a significant CAGR in the coming years, owing to the increasing adoption of outpatient services for continuous blood pressure monitoring during medical procedures. Ambulatory surgical centers are specialized healthcare facilities that provide surgical and procedural services on an outpatient basis. These centers offer a cost-effective and convenient alternative to traditional hospital settings for various surgical interventions.
The home healthcare segment is expected to grow at a rapid pace during the forecast period, owing to the growing requirement to minimize unnecessary visits to hospitals. Ability of ABPM devices to continuously monitor the blood pressure of patients outside the clinical environment is particularly beneficial for home care settings, where regular and comprehensive monitoring is crucial for optimal patient management. Rising disposable income of consumers is likely to fuel the segment.
Regional Outlook
In terms of region, the global ambulatory blood pressure monitoring devices market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the forecast period, owing to the well-developed healthcare infrastructure, technological advancements, and high prevalence of hypertension conditions.
North America has a well-developed healthcare infrastructure, including advanced medical facilities, strong reimbursement systems, and high level of healthcare expenditure. This supports the widespread adoption and utilization of ambulatory blood pressure monitoring devices in various healthcare settings, such as hospitals, clinics, and ambulatory care centers. Availability of modern healthcare facilities and resources contributes to the market expansion in the region.
Hypertension is a common chronic condition in the region that affects a substantial portion of the population. Need for accurate and continuous blood pressure monitoring to diagnose, treat, and manage hypertension has propelled the demand for ambulatory blood pressure monitoring devices in the region.
The market in Asia Pacific is anticipated to expand at a rapid pace in the coming years, due to the growing incidence of hypertension, increasing healthcare expenditure, and rising awareness about cardiovascular health. Prevalence of hypertension and cardiovascular diseases is high in this region. The large population base contributes to the demand for ABPM devices, which boosts the market in the region. The regional market growth is further attributed to the growing awareness about cardiovascular health and the need for blood pressure monitoring.
-
According to WHO, hypertension is the primary factor for cardiovascular diseases. About 63% of total deaths in India are caused by non-communicable diseases, of which 27% are attributed to cardiovascular disease caused by hypertension.Only 12%of people with hypertension in India have blood pressure under control.
Segments
The global ambulatory blood pressure monitoring devices market has been segmented on the basis of
Product Type
- Arm Devices
- Wrist Devices
End-user
- Hospitals
- Ambulatory Surgical Centers
- Home Healthcare
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Welch Allyn®
- BOSCH + SOHN GmbH u. Co. KG
- Vaso Corporation
- SunTech Medical, Inc
- Schiller AG
- Rudolf Riester GmbH
- OSI Systems, Inc
- OMRON Healthcare, Inc
- Halma Plc
- GE HealthCare
- Daifuku Co., Ltd.
- CONTEC MEDICAL SYSTEMS CO.,LTD
- BPL Limited
- Baxter
Competitive Landscape
Key players competing in the global ambulatory blood pressure monitoring devices market are Welch Allyn®; Vaso Corporation; SunTech Medical, Inc; Schiller AG; Rudolf Riester GmbH; OSI Systems, Inc; OMRON Healthcare, Inc; Halma Plc; GE HealthCare; Daifuku Co., Ltd.; CONTEC MEDICAL SYSTEMS CO., LTD; BPL Limited; BOSCH + SOHN GmbH u. Co. KG; and Baxter.
These companies are boosting their market share by adopting various strategies, such as partnerships, mergers, reduction in production costs, launch of products, and implementation of advanced technologies.
-
On September 3, 2021, SunTech Medical, a provider of medical blood pressure monitoring products, announced the completion of the acquisition of Meditech Kft,a manufacturer of quality ambulatory blood pressure and ECG monitor devices. This acquisition utilizes the expertise of both companies to offer healthcare solutions.
Request For Customization
Enquiry Before Buying
Speak With Analyst
